Add to Calendar WCM-Q Grand Rounds 1/28/2024 3:30:00 PM 1/28/2024 4:30:00 PM Asia/Riyadh For More Details: https://wcmq.cloud-cme.com/course/courseoverview?EID=3440 Description: WCM-Q Grand Rounds is a lecture series with the aim of providing physicians and other healthcare practitioners updates on current issues related to healthcare. Grand Rounds have been long an integral part of the education of physicians and this series will be delivered in a format that promotes presenter/audience interactions. The series will not focus on any one area speciality but offer an array of mul... Livestreamed (Zoom) false MM/DD/YYYY


Date & Location
Occurs every 2 weeks on Sunday starting on 1/28/2024 at 3:30 PM
Sunday, January 28, 2024, 3:30 PM - 4:30 PM, Livestreamed (Zoom)

Overview
WCM-Q Grand Rounds is a lecture series with the aim of providing physicians and other healthcare practitioners updates on current issues related to healthcare. Grand Rounds have been long an integral part of the education of physicians and this series will be delivered in a format that promotes presenter/audience interactions. The series will not focus on any one area speciality but offer an array of multidisciplinary topics. WCM-Q Grand Rounds will be held twice per month. Each lecture will be maximum of one hour in length , including 15 mins for a question and answer period. Participants will benefit from the opportunity to discuss topics that can help in the improvement of patient care.

Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Students

Overall Learning Objective
  1. Identify key factors and challenges in addressing a variety of health needs generally and also apply them to the local cultural expectations.
  2. Discuss the impact this expanded knowledge has on their ability to diagnose or assess the patient.
  3. Identify the benefits the gained knowledge has on developing a multidisciplinary approach to patient care.

Registration
No Registration Fee

Accreditation

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 1.00 hour.


ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Tariq Chukir, MD, Thurayya Arayssi, MD, Sohaila Cheema, MBBS, Deema Al-Sheikhly, MRes, MEPH, Christopher Triggle, PhD, Andrew Jones, BSN, Phyllis Sui Muffuh Navti, Doctorate in Pharmacy Practice, Reshma Bholah, MD, Constatina Dalassou, DDS, Devin Thompson, RT, have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Jamie M. Gray, MLS, has disclosed the following relationships: Stocks or Stock Options, excluding diversified mutual funds - Proctor & Gamble and Colgate-Palmolive

 All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Leena Amine, PharmD, has disclosed the following relationship: Consulting Fee - Wolters Kluwer

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Faculty: Ayman Al Jurdi, MD, Samah Musa, MD, Kurt Kleinschmidt, MD, FACMT, FASAM, Rudaina Hassan, BSC (HONS), DFSRH, MBBS, MRCOG, Taseer Din, MBChB, FCORL, MMED, Zaid Tafesh,MD, MSc, Ali Rahil, MBChB, ABIM, MRCP (UK), FRCP (Edinburgh), MRCP (Endocrine), PGDip DM (UK) have no relevant financial/non-financial relationships with any for-profit /not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products. 

Mohamed Hassanein, FRCP, CCST, MPHIL, MBCHB, has disclosed the following relationships: Speakers Bureau - Novonordisk, EliLilly and Sanofi

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Jaime Almandoz, MD, MBA, MRCPI, FTOS has disclosed the following relationships: Advisor - Novo Nordisk, Boehringer Ingelheim and Eli Lilly & Company 

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Rachel Stahl Salzman, MS, RD, CDN, CDCES has disclosed the following relationships: Stock Options Holder - Undermyfork; Board Member, Advisory Committee Member, Review Panel Member - Medtronic, Mannkind, Sanofi and Undermyfork

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Jones Nauseef, MD, PhD has disclosed the following relationships: Employee - Convergent Therapeutics; Consultant - Pfizer, Honorarium Recipient - Bayer  

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Jennifer Adams, MD has disclosed the following relationships: Membership on Advisory Committees or Review Panels, Board Membership - Bowdoin college, Xavier University Of Louisianna, Boardman Cottage and POLG foundation

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Administrative Contacts: Asha Fernandes, Safia Rabia, have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

ICR: Tariq Chukir, MD, has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.